Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.

Sidsel Pedersen,Rikke B Holmstroem,Annika von Heymann,Laerke K Tolstrup,Kasper Madsen,Morten Aagaard Petersen,Charlotte A Haslund,Christina H Ruhlmann,Henrik Schmidt,Christoffer Johansen,Inge Marie Svane,Eva Ellebaek

Acta oncologica (Stockholm, Sweden)（2023）

引用 3|浏览6

暂无评分

摘要

Adjuvant nivolumab may affect some aspects of QoL, but the influence seems temporary. Patient characteristics, such as civil status, employment status, and comorbidity were associated with HRQoL.

查看译文

关键词

Melanoma,adjuvant therapy,health-related quality of life,immunotherapy,nivolumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要